Recent World Health Organization (WHO) Study Shows Efficacy of Tobacco Control Laws

By | Leave a Comment

This post was written by Belen Rios, Research Assistant, Global Health LL.M. ‘13, at the O’Neill Institute for National and Global Health Law. Any questions or comments about this post can be directed to mbr55@georgetown.edu. A recent study published by the World Health Organization (WHO) has shown that the adoption of tobacco control laws around the […]

Posted in uncategorized ; Tagged: , , , , , , , , , , , .


Nudging one’s way to a healthy lifestyle – A look at regulations in health through the lens of behavioral economics

By | Leave a Comment

This post was written by Mengyi Xu, O’Neill Institute Summer Intern, Princeton University ’14.  Any comments or questions about this post can be directed to mxu@princeton.edu. To regulate or not to regulate, that is always the question. On the opening day of the O’Neill Institute’s Summer Program on NCDs and law, Professor Alberto Alemanno from HEC […]

Posted in uncategorized ; Tagged: , , , , , , , , , .


The AMA Recognizes Obesity as a Disease – Why the controversy surrounding this decision is missing the point and why this decision is the good one?

By | Leave a Comment

This post was written by Florian Kastler (Global Health LL.M. 2011), visiting researcher at Georgetown University Law Center. Any comments or questions about this post can be directed to florian.kastler@gmail.com. By a decision overriding its own council on Science and Public Health, the house of delegates of the American Medical Association (AMA) has officially recognized […]

Posted in uncategorized ; Tagged: , , , , , , , , , , , .


The End of “Pay-for-Delay”? By Opening Collusive Pharmaceutical Settlements to Antitrust Scrutiny, FTC v. Actavis Promises to Make Medicines More Affordable

By | Leave a Comment

  In a decision that could save U.S. consumers and taxpayers billions of dollars a year, the Supreme Court ruled Monday that “pay-for-delay,” also known as “reverse payment” settlements, between name-brand and generics pharmaceutical companies are subject to antitrust laws. The seeds of the controversy were planted in 1984 with the passage of the Hatch-Waxman […]

Posted in Healthcare, uncategorized ; Tagged: , , , , .


2013 Summer Program Day 2!

By | Leave a Comment

Our 2013 Summer Program on non-communicable diseases (NCDs) is underway! Here’s what our participants have to look forward to on Day 2.

Posted in uncategorized ; Tagged: , , , , , .


Lessons from the Industry

By | Leave a Comment

In her opening remarks to the 8th Global Conference on Health Promotion, Margaret Chan, Director General of the World Health Organization (WHO) warned: [e]fforts to prevent non-communicable diseases go against the business interests of powerful economic operators. In my view, this is one of the biggest challenges facing health promotion . . . [i]t is […]

Posted in FCTC, Global Health, Human Rights, Resources, Tobacco, uncategorized, WHO ; Tagged: , , , , , , , .


Health Privacy Summit

By | Leave a Comment

On June 5 and 6 the O’Neill Institute for National and Global Health Law and Patient Privacy Rights co-hosted a two-day health privacy summit on the Georgetown University Law Center campus. This year’s discussions included the challenges of ensuring personal control over health information in the face of rapid global deployment of healthcare IT and […]

Posted in uncategorized ; Tagged: , , , , , , .


Health Implications of Coca-Cola Investment in Myanmar?

By | Leave a Comment

This post was written by Benn McGrady, Project Director of the O’Neill Institute’s Trade, Investment, and Health Initiative.  It was originally published on the O’Neill Institute’s Trade, Investment, and Health Initiative Blog.  Any comments or questions about this post can be directed to bm363@law.georgetown.edu.   To much fanfare in the US media Coca-Cola has announced […]

Posted in uncategorized ; Tagged: , , , , , , , , , .


A Surprising U.S. Intervention at the 66th World Health Assembly Breathes Life Into a Proposed WHO Biomedical R&D Treaty

By | Leave a Comment

For those hoping for a biomedical research and development treaty, the 2013 World Health Assembly (WHA) concluded with a glimmer of hope.  The WHA both called for greater study into current research and development trends and adopted an unexpected U.S. proposal to convene a series of advisory meetings, tasked with developing demonstration projects intended to […]

Posted in uncategorized ;


O'Neill Institute Blog on Trade, Investment, and Health

By | Leave a Comment

Please check out the O’Neill Institute’s blog on Trade, Investment, and Health.  Part of the O’Neill Institute’s Initiative on Trade, Investment, and Health, the blog examines current and emerging issues at the intersection of these fields. Recent posts include: GMO Wheat leads to Import Restrictions in Japan and Korea. EU– India FTA Negotiations: Opening a New […]

Posted in uncategorized ; Tagged: , , , , , , , , .

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.